More doses of Shingrix are on the way, GlaxoSmithKline says

GlaxoSmithKline, the maker of the shingles vaccine Shingrix that has been in short supply, told customers Jan. 10 that more shipments of the vaccine are on the way to U.S. pharmacies, according to WebMD.

While more doses are on the way, the company warned that demand may still outpace supply.

GlaxoSmithKline has ordering limits in place, so a single provider can't order and maintain a large stock.  

This year the company said it  plans to ramp up the frequency and volume of doses shipped.

More articles on supply chain:
3 digital health moves the FDA made in 2018
Novartis, VC firms invest $64M in 'digital therapeutics' company
BTG Pharmaceuticals tracks snake-bite treatment with blockchain in partnership with OMNY

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months